ACTIVE

Apotheek Duinenwater

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result221,4 k €+26,0 %over 1 year
Gross margin348,2 k €+8,4 %over 1 year
Equity199,2 k €+26,3 %over 1 year
Workforce1,3 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Apotheek Duinenwater is a Private limited company incorporated in 2005. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Knokke-Heist. It employs on average 1,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0876.658.779
Incorporation
13/10/2005
Legal form
Private limited company
Registered office
Duinenwater 5
8300 Knokke-Heist · FlandreSee on map
Contributed capital
75 000,00 €
Latest accounts
31/12/2025
Average workforce
1,3 ETP
Joint committees (3)
  • 313
  • 31300
  • 313000
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 18 financial years

20252024202320232022
Income statement
Gross margin348,2 k €321,2 k €229,1 k €318 k €313,7 k €
EBITDA269,2 k €216,4 k €136,9 k €205,7 k €245,9 k €
Operating result237,7 k €185 k €114,2 k €177,4 k €215,1 k €
Net result221,4 k €175,7 k €105,1 k €167,8 k €214,1 k €
Balance sheet
Equity199,2 k €157,8 k €132,1 k €106,9 k €79,2 k €
Total assets677,1 k €614,7 k €695,6 k €613,4 k €672,1 k €
Cash140,1 k €137,2 k €166 k €112,5 k €174,8 k €
Debts477,8 k €456,1 k €563,5 k €505,9 k €592,3 k €
Other
Workforce1,3 ETP1,3 ETP2,1 ETP2,2 ETP1,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 10 ended

Active mandates

MELLOW PHARMA

Director · since 01 octobre 2020 · 0754.801.045

Represented by Lowagie Mélanie

Active
Mediwire

Director · since 01 avril 2017 · 0661.686.983

Represented by Reynders Charlotte

Active

Ended mandates

MELLOW PHARMA

Director · since 01 octobre 2020 · 0754.801.045

Represented by Lowagie MÉLANIE

Ended
Mediwire

Director · since 01 avril 2017 · 0661.686.983

Represented by Reynders CHARLOTTE

Ended
Anne Maertens

Manager · since 13 octobre 2005

Ended
Anne Maertens

Mandate

Ended

Full financial information

Source · NBB
202520242023202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202501/01/202401/04/202301/04/202201/04/202101/04/2020
Closing of the financial year31/12/202531/12/202431/12/202331/03/202331/03/202231/03/2021
Length of the financial year12 months12 months9 months12 months12 months12 months
Filing date31/08/202629/08/202511/07/202420/10/202302/11/202228/10/2021
General meeting18/07/202628/06/202529/06/202416/09/202317/09/202218/09/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202518/07/202631/08/2026DutchPDF
Abridged model31/12/202428/06/202529/08/2025DutchPDF
Abridged model31/12/202329/06/202411/07/2024DutchPDF
Abridged model31/03/202316/09/202320/10/2023DutchPDF
Abridged model31/03/202217/09/202202/11/2022DutchPDF
Micro model31/03/202118/09/202128/10/2021DutchPDF
Abridged model31/03/202019/09/202030/10/2020DutchPDF
Abridged model31/03/201921/09/201925/09/2019DutchPDF
Abridged model31/03/201815/09/201830/10/2018DutchPDF
Abridged model31/03/201716/09/201716/10/2017DutchPDF
Abridged model31/12/201518/06/201612/07/2016DutchPDF
Abridged model31/12/201420/06/201508/07/2015DutchPDF
Abridged model31/12/201321/06/201416/07/2014DutchPDF
Abridged model31/12/201215/06/201309/07/2013DutchPDF
Abridged model31/12/201116/06/201204/07/2012DutchPDF
Abridged model31/12/201018/06/201105/07/2011DutchPDF
Abridged model31/12/200919/06/201028/06/2010DutchPDF
Abridged model31/12/200820/06/200930/06/2009DutchPDF
Abridged model31/12/200712/07/200812/08/2008DutchPDF
Abridged model31/12/200607/07/200731/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 10 ended

Active mandates

MELLOW PHARMA

Director · since 01 octobre 2020 · 0754.801.045

Represented by Lowagie Mélanie

Active
Mediwire

Director · since 01 avril 2017 · 0661.686.983

Represented by Reynders Charlotte

Active

Ended mandates

MELLOW PHARMA

Director · since 01 octobre 2020 · 0754.801.045

Represented by Lowagie MÉLANIE

Ended
Mediwire

Director · since 01 avril 2017 · 0661.686.983

Represented by Reynders CHARLOTTE

Ended
Anne Maertens

Manager · since 13 octobre 2005

Ended
Anne Maertens

Mandate

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates11/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates29/10/2020
    ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
    PDF
  • Registered office06/07/2017
    BENAMING - MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates11/05/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other02/01/2017
    ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates16/04/2007
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares25/08/2006
    KAPITAAL - AANDELEN
    PDF
  • Other26/10/2005
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025221,4 k €↑
  2. 2024
    Annual accounts 2024175,7 k €↑
  3. 2023
    Annual accounts 2023105,1 k €↓
  4. 2023
    Annual accounts 2023167,8 k €↓
  5. 2022
    Annual accounts 2022214,1 k €↑
  6. 2019
    Annual accounts 201923,1 k €↑
  7. 2018
    Annual accounts 2018-96 k €↓
  8. 2017
    Annual accounts 20179,5 k €↑
  9. 2015
    Annual accounts 2015-4,7 k €↓
  10. 2014
    Annual accounts 20142,1 k €↑
  11. 2013
    Annual accounts 2013-13,6 k €↓
  12. 2012
    Annual accounts 2012-9,5 k €↓
  13. 2011
    Annual accounts 2011-8,3 k €↓
  14. 2010
    Annual accounts 2010-4,9 k €↓
  15. 2009
    Annual accounts 2009792 €↑
  16. 2008
    Annual accounts 2008-11,1 k €↓
  17. 2007
    Annual accounts 2007-1,9 k €↓
  18. 2006
    Annual accounts 2006-1,9 k €
  19. 13/10/2005
    IncorporationPrivate limited company